eMJA: Correction - Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase

Correction

Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase

Matthew G Law and Robert G Batey

MJA 2003; 178 (10): 494

Re: Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase, by Law MG and Batey RG in the 3 March 2003 issue of the Journal (Med J Aust 2003; 178: 197-198). Dr Batey's position was incorrectly given as Director, Gastroenterology Department, John Hunter Hospital. His position is Clinical Chair, Division of Medicine, John Hunter Hospital.

The html and pdf versions of the article on the website were corrected on 12 May 2003.

(Received 21 Mar 2003, accepted 21 Mar 2003)

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW.

Matthew G Law, PhD, Statistician.

Division of Medicine, John Hunter Hospital, Newcastle, NSW.

Robert G Batey, MD FRACP FRCP, Clinical Chair.

Correspondence: Dr Matthew G Law, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, NSW 2010. mlawATnchecr.unsw.edu.au

AntiSpam note: To avoid spam, authors' email addresses are written with AT in place of the usual symbol, and we have removed "mail to" links. Replace AT with the correct symbol to get a valid address.

The Medical Journal of Australia eMJA